GleamWall
中文EN

OGI ORGANIGRAM GLOBAL INC. IFRS Annual reports only

Pharmaceutical Preparations · Nasdaq · SEC CIK 1620737 · Reporting currency CAD · Fiscal year ends 09/30

Financial factors as of 2022-08-31 (FY2022), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY84.2%
TTM net income YoY89.1%
TTM EPS YoY63.9%
Revenue 3-yr CAGR21.9%
Net income 3-yr CAGR—

Margins

Gross margin21.7%
Operating margin-29.6%
Net margin-9.8%
FCF margin-58.3%
EBITDA margin-26.0%

Returns

ROE-2.9%
ROA-2.5%
ROIC (approx.)-7.9%
Asset turnover0.26x

Leverage & solvency

Liabilities / assets12.0%
Debt / equity0.00x
Current ratio4.01x
Interest coverage-100.59x

Cash quality & payout

Operating cash flow / net income2.54x
Accruals ratio3.9%
Payout ratio—
Capex / revenue33.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: CAD FY2024*2024-09-30FY2022*2022-08-31
Income statement
Revenue159.84M145.81M
Cost of revenue111.39M119.04M
Gross profit47.52M31.57M
R&D expense11.20M5.96M
SG&A expense45.87M42.91M
Operating income-35.67M-43.15M
Interest expense—429,000
Pretax income-45.44M-14.37M
Income tax0-88,000
Net income-45.44M-14.28M
EBITDA-31.82M-37.85M
EPS (basic)-0.48-0.18
EPS (diluted)-0.48-0.18
Weighted avg. shares (diluted)95.29M77.23M
Balance sheet
Cash & equivalents106.75M68.52M
Receivables37.15M46.37M
Inventory67.35M50.31M
Current assets262.22M221.62M
PP&E, netmay include right-of-use assets (IFRS)96.23M259.82M
Intangibles—56.24M
Total assets407.86M577.11M
Current liabilities53.32M55.28M
Short-term debt60,00080,000
Long-term debt25,000155,000
Total debt85,000235,000
Total liabilities101.87M69.05M
Shareholders' equity305.99M508.06M
Net debt-106.66M-68.28M
Shares outstanding108.59M78.45M
Cash flow statement
Operating cash flow3.87M-36.21M
Capital expenditure4.73M48.75M
Free cash flow-859,000-84.96M
Investing cash flow-38.77M44.03M
Financing cash flow107.78M5.33M
Depreciation & amortization3.85M5.30M
Stock-based compensation7.18M5.13M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.